Table 2.

Baseline Medication Use during the 30 Days before Study Enrollment

Medication	WAAP Group (n = 200) [n (%)]	Control Group (n = 201) [n (%)]	P Value
Short-acting β-agonists	198 (99)	197 (98)	0.72
LABAs	0 (0)	2 (1)	0.59
ICS	116 (58)	101 (50)	0.06
Systemic corticosteroids	100 (50)	84 (42)	0.12
Leukotriene antagonists	120 (60)	114 (57)	0.64
Combination LABA + ICS	62 (31)	72 (36)	0.38

Definition of abbreviations: ICS = inhaled corticosteroids; LABA = long-acting β-agonist; WAAP = written asthma action plan.